Otago researchers get nearly $1 million to research prostate cancer protein

NZ HERALD: Otago University biomedical researchers have been awarded a $950,000 Health Research Council Grant for a three-year project to investigate the likely role of a protein, activin C, in promoting prostate cancer growth.

Read Full Post »

Poker-playing ex-pat Yank has written book about prostate cancer

NZ HERALD: He’s a doctor who has written a book on prostate cancer, he’s built a wellness retreat at Abel Tasman National Park and his hobbies include nutrition.

Read Full Post »

Obesity drug tested on mice also affects prostate cancer cells

YAHOO XTRA NEWS: Researchers searching for a cure for obesity have developed a drug that not only makes mice lose weight, but reverses diabetes, lowers their cholesterol, has effects on prostate cancer cells – something that may help explain links between prostate cancer and obesity.

Read Full Post »

NZ’s drug agency, Pharmac, agrees to fund prostate drug for another three years

NZ DOCTOR: Restrictions on access to intravenous prostate cancer treatment drug Zoladex (goserelin) will be lifted tomorrow in an agreement that sees Pharmac continuing to fully subsidise the drug.

Read Full Post »

Tomatoes turn blue in Wattie’s efforts to support prostate cancer awareness month

PROSTABLOG NZ: Canned food giant Wattie’s is doing its bit to support the NZ Prostate Cancer Foundation’s Blue September campaign by donating 5c a can from every sale of Wattie’s canned tomato sauce and Wattie’s canned tomato products featuring the Blue September label.

Read Full Post »

Suspicion grows over how terminal freed Lockerbie bomber’s prostate cancer is

SUNDAY HERALD (SCOTLAND): Suspicions are growing about the prostate cancer medical evidence used to justify the release of the man convicted of the Lockerbie bombing

Read Full Post »

Blue September dawns in NZ – see coverage here

PROSTABLOG NZ: Blue September – the Prostate Cancer Foundation of NZ’s annual awareness campaign – has started already

Read Full Post »

Mobile clinic takes health checks for diseases like prostate cancer into American Indian communities

SHAKOPEE VALEY NEWS: A $2 million, 16-wheel mobile unit with leather seats, computers, flat-screen televisions and state-of-the-art medical technology is being used to bring medical testing to American Indian populations in Minnesota.

Read Full Post »

Prostate cancer patients round world being tested with new anti-cancer agent that blocks tumour growth

PSA RISING.COM: A potential anti-cancer agent called ZD4054 is being tested in clinical trials around the world in patients with prostate cancer to see if it can block the uptake of endothelin A and thereby shrink tumors or slow their progression.

Read Full Post »

New antagonist hormone drug overtakes 25-year-old agonist versions for treating advanced prostate cancer

URO TODAY: Degarelix, a recently approved LHRH antagonist, has been shown to work more quickly in lowering serum testosterone levels, with an acceptable safety profile and a mechanism of action that obviates the testosterone surges associated with LHRH agonist use.

Read Full Post »